Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| Massively targeted evaluation of therapeutic CRISPR off-targets in cells. | Nat Commun | 2022 | 35831290 | PubTator, text mining | PubMed |
| The consequences of viral infection on host DNA damage response: a focus on SARS-CoVs. | J Genet Eng Biotechnol | 2022 | 35829826 | PubTator, text mining | PubMed |
| Features of Hemophagocytic Lymphohistiocytosis in Infants With Severe Combined Immunodeficiency: Our Experience From Chandigarh, North India. | Front Immunol | 2022 | 35812426 | PubTator, text mining | PubMed |
| Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a NHEJ1-Deficient Long-term Survivor. | Front Immunol | 2022 | 35812385 | PubTator, text mining | PubMed |
| The contribution of DNA repair pathways to genome editing and evolution in filamentous pathogens. | FEMS Microbiol Rev | 2022 | 35810003 | PubTator, text mining | PubMed |
| Design of SARS-CoV-2 Main Protease Inhibitors Using Artificial Intelligence and Molecular Dynamic Simulations. | Molecules | 2022 | 35807268 | PubTator, text mining | PubMed |
| Human Stem Cell and Organoid Models to Advance Acute Kidney Injury Diagnostics and Therapeutics. | Int J Mol Sci | 2022 | 35806216 | PubTator, text mining | PubMed |
| Increased Resection at DSBs in G2-Phase Is a Unique Phenotype Associated with DNA-PKcs Defects That Is Not Shared by Other Factors of c-NHEJ. | Cells | 2022 | 35805183 | PubTator, text mining | PubMed |
| Structural analysis of the basal state of the Artemis:DNA-PKcs complex. | Nucleic Acids Res | 2022 | 35801871 | PubTator, text mining | PubMed |
| Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer. | Medicine (Baltimore) | 2022 | 35801800 | PubTator, text mining | PubMed |
| A structural homology approach to identify potential cross-reactive antibody responses following SARS-CoV-2 infection. | Sci Rep | 2022 | 35794133 | PubTator, text mining | PubMed |
| Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV. | Cell Rep Methods | 2022 | 35784645 | PubTator, text mining | PubMed |
| Analysis of diverse double-strand break synapsis with Polλ reveals basis for unique substrate specificity in nonhomologous end-joining. | Nat Commun | 2022 | 35778389 | PubTator, text mining | PubMed |
| POLQ suppresses genome instability and alterations in DNA repeat tract lengths. | NAR Cancer | 2022 | 35774233 | PubTator, text mining | PubMed |
| [Correlation of polymorphisms of DNA double-strand break repair genes XRCC5, LIG4 and glioma]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2022 | 35773772 | PubTator, text mining | PubMed |
| The importance of DNAPKcs for blunt DNA end joining is magnified when XLF is weakened. | Nat Commun | 2022 | 35760797 | PubTator, text mining | PubMed |
| The Chromatin Landscape Channels DNA Double-Strand Breaks to Distinct Repair Pathways. | Front Cell Dev Biol | 2022 | 35757003 | PubTator, text mining | PubMed |
| Inborn errors of immunity caused by defects in the DNA damage response pathways: Importance of minimizing treatment-related genotoxicity. | Pediatr Allergy Immunol | 2022 | 35754136 | PubTator, text mining | PubMed |
| Medulloblastoma and the DNA Damage Response. | Front Oncol | 2022 | 35747808 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=26